Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Liu, Ming Fei ^a   Weng, Chia Tse ^a   Weng, Meng Yu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LIGAND; PROGRAMMED DEATH 1; PROGRAMMED DEATH 1 LIGAND; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CD14 ANTIGEN; CD274 PROTEIN, HUMAN; CYTOKINE; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PDCD1 PROTEIN, HUMAN; PDCD1LG2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; BIOSYNTHESIS; BLOOD; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; NONPARAMETRIC TEST; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, CD19; ANTIGENS, CD3; APOPTOSIS REGULATORY PROTEINS; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 70350009858     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/406136     Document Type: Article

References (27)

1. Greenwald R. J., Freeman G. J., Sharpe A. H., The B7 family revisited Annual Review of Immunology 2005 23 515 548
2. Okazaki T., Iwai Y., Honjo T., New regulatory co-receptors: inducible co-stimulator and PD-1 Current Opinion in Immunology 2002 14 6 779 782
3. Freeman G. J., Long A. J., Iwai Y., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation Journal of Experimental Medicine 2000 192 7 1027 1034
4. Latchman Y., Wood C. R., Chernova T., PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nature Immunology 2001 2 3 261 268
5. Nishimura H., Minato N., Nakano T., Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses International Immunology 1998 10 10 1563 1572
6. Nishimura H., Nose M., Hiai H., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 1999 11 2 141 151
7. Nishimura H., Okazaki T., Tanaka Y., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 2001 291 12 319 322
8. Ansari M. J. I., Salama A. D., Chitnis T., The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice Journal of Experimental Medicine 2003 198 1 63 69
9. Salama A. D., Chitnis T., Imitola J., Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis Journal of Experimental Medicine 2003 198 1 71 78
10. Hatachi S., Iwai Y., Kawano S., CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid Journal of Rheumatology 2003 30 7 1410 1419
11. Kanai T., Totsuka T., Uraushihara K., Blockade of B7-H1 suppresses the development of chronic intestinal inflammation Journal of Immunology 2003 171 8 4156 4163
12. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic Lupus erythematosus Arthritis RheumLupus 1982 25 5 1271 1277
13. Liang S. C., Latchman Y. E., Buhlmann J. E., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses European Journal of Immunology 2003 33 10 2706 2716
14. Yamazaki T., Akiba H., Iwai H., Expression of programmed death 1 ligands by murine T cells and APC Journal of Immunology 2002 169 10 5538 5545
15. Ishida M., Iwai Y., Tanaka Y., Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues Immunology Letters 2002 84 1 57 62
16. Eppihimer M. J., Gunn J., Freeman G. J., Expression and regulation of the PD-L1 immunoinhibitory molecule on micro vascular endothelial cells Microcirculation 2002 9 2 133 145
17. Schoop R., Wahl P., Le Hir M., Suppressed T-cell activation by INF- -induced expression of PD-L1 on renal tubular epithelial cells Nephrology Dialysis Transplantation 2004 19 11 2713 2720
18. Nakazawa A., Dotan I., Brimnes J., The expression and function of costimulatory molecules B7h and B7-H1 on colonic epithelial cells Gastroenterology 2004 126 5 1347 1357
19. Keir M. E., Liang S. C., Guleria I., Tissue expression of PD-L1 mediates peripheral T cell tolerance Journal of Experimental Medicine 2006 203 4 883 895
20. Hatachi S., Iwai Y., Kawano S., CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid Journal of Rheumatology 2003 30 7 1410 1419
21. Kobayashi M., Seiji K., Saori H., Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogrens syndrome Journal of Rheumatology 2005 32 11 2156 2163
22. Tsutsumi Y., Ihara K., Nomura A., Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with type-1 diabetes Diabetic Medicine 2006 23 1145 1150
23. Youngnak-Piboonratanakit P., Tsushima F., Otsuki N., The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role Immunology Letters 2004 94 3 215 222
24. Ansari M. J. I., Salama A. D., Chitnis T., The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice Journal of Experimental Medicine 2003 198 1 63 69
25. Salama A. D., Chitnis T., Imitola J., Akiba H., Tushima F., Azuma M., Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis Journal of Experimental Medicine 2003 198 1 71 78
26. Kanai T., Totsuka T., Uraushihara K., Blockade of B7-H1 suppresses the development of chronic intestinal inflammation Journal of Immunology 2003 171 8 4156 4163
27. Loke P., Allison J. P., PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells Proceedings of the National Academy of Sciences of the United States of America 2003 100 9 5336 5341